Who
Paul Andrew Gendron
Director
Company insider
Files Form 4 as: Director, InfuSystems Holdings.
In numbers
- Trades disclosed
- 17
- Buys
- 5
- Sells
- 0
- Bought
- $347K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 15 May 2019
- Last trade
- 12 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 14 May 2026 | INFU InfuSystems Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —24,890 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | INFU InfuSystems Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —24,890 at $0.00 | filing |
| 8 May 2026filed 12 May 2026 | INFU InfuSystems HoldingsMedical Devices | SEC FORM 4 Bought | $44K5,000 at $8.88 | filing |
| 8 May 2026filed 12 May 2026 | INFU InfuSystems HoldingsMedical Devices | SEC FORM 4 Bought | $44K5,000 at $8.88 | filing |
| 16 May 2025filed 20 May 2025 | INFU InfuSystems Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —39,588 at $0.00 | filing |
| 20 May 2024filed 21 May 2024 | INFU InfuSystems HoldingsMedical Devices | SEC FORM 4 Bought | $33K5,000 at $6.54 | filing |
| 17 May 2024filed 21 May 2024 | INFU InfuSystems Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —35,685 at $0.00 | filing |
| 18 May 2023filed 19 May 2023 | INFU InfuSystems Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —24,424 at $0.00 | filing |
| 17 May 2022filed 17 May 2022 | INFU InfuSystems Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 11 Feb 2022filed 15 Feb 2022 | INFU InfuSystems HoldingsMedical Devices | SEC FORM 4 Bought | $107K10,000 at $10.67 | filing |
| 11 Nov 2021filed 12 Nov 2021 | INFU InfuSystems Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 11 Nov 2021filed 12 Nov 2021 | INFU InfuSystems HoldingsMedical Devices | SEC FORM 4 Code M | $118K25,000 at $4.70 | filing |
| 18 May 2021filed 20 May 2021 | INFU InfuSystems Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 25 Mar 2021filed 29 Mar 2021 | INFU InfuSystems HoldingsMedical Devices | SEC FORM 4 Bought | $61K3,000 at $20.34 | filing |
| 20 May 2020filed 22 May 2020 | INFU InfuSystems Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 23 Mar 2020filed 25 Mar 2020 | INFU InfuSystems HoldingsMedical Devices | SEC FORM 4 Bought | $58K10,000 at $5.77 | filing |
| 15 May 2019filed 16 May 2019 | INFU InfuSystems Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
Comparing InfuSystem (NYSE:INFU) & Pediatrix Medical Group (NYSE:MD)INFU · tickerreport.com · 12 Oct 2026
0 headlines in the last 90 days name Paul Andrew Gendron; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.